|Day Low/High||2.25 / 2.46|
|52 Wk Low/High||1.65 / 5.05|
We still like all of these names after developments this week.
During the week we scaled into two existing positions and added back shares of a former holding.
During the week we added to our cannabis play Kush Bottles and took a nice win on J.Jill.
Last week we trimmed USA Technologies and added LendingClub to the Bullpen.
ACRX has reached our price target, so we’re being disciplined.
We trimmed one position for a hefty gain last week, as the portfolio delivered very favorable performance on both an absolute and relative basis.
We added 2 new positions during a week of solid performance for the portfolio.
During a down week for the market, we exited one name and added to another.
Here’s our plan for AcelRx Pharmaceuticals leading up to earnings.
We added to two positions during a week when nearly all of our holdings moved higher.
We exited one name and added to another during a wild week for stocks.
The portfolio had several market outperformers last week and we took some profits in one high-flying position.
During a ‘noisy’ week for the portfolio, we added a small speculative position in a payment-processing name.
We will sell shares of AcelRx Pharmaceuticals and buy more Black Box.
The strength exhibited by the Russell 2000 paved the way for portfolio last week.
We threw in the towel last week on 2 positions and initiated a small stake in an ancillary cannabis play.
During a shortened trading week we closed out of one position and added to another after earnings reports.
We added to several positions on weakness during a challenging last week for the stock market.
We exited one position and added to another as volatility returned to the stock market last week.
It was a mixed week for the portfolio as we trimmed one position and added to the Bullpen.
Last week, we closed a position for a large gain and used some of the proceeds to start a small stake in a fracking and desalination name.
Despite a shortened trading week, we made a series of moves, including initiating a position in GSV Capital.
During a quiet week for the market, we added to two positions and trimmed three others.
We will buy more AcelRx Pharmaceuticals and sell shares of Inovio Pharmaceuticals as we close out 2017.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.